Showing 1 - 8 results of 8 for search 'I. A. Leneva', query time: 0.02s Refine Results
  1. 1
    Antiviral Activity of Interferon Alpha-2b and Taurine Combination Against SARS-CoV-2 in vitro

    Antiviral Activity of Interferon Alpha-2b and Taurine Combination Against SARS-CoV-2 in vitro by N. P. Kartashova, A. V. Ivanina, E. A. Glubokova, I. N. Falynskova, A. A. Poromov, I. A. Leneva

    Published 2022-12-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Susceptibility of Pandemic Influenza Virus A 2009 H1N1 and Highly Pathogenic Avian Influenza Virus A H5N1 to Antiinfluenza Agents in Cell Culture

    Susceptibility of Pandemic Influenza Virus A 2009 H1N1 and Highly Pathogenic Avian Influenza Virus A H5N1 to Antiinfluenza Agents in Cell Culture by I. T. Fedyakina, M. YU. Shchelkanov, P. G. Deryabin, I. A. Leneva, N. V. Gudova, T. V. Kondratyeva, D. K. Lvov

    Published 2020-05-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Local antiviral activity of the drug «Thymogen®», nasal dosed spray, against SARS-CoV-2 coronavirus <i>in vitro</i>

    Local antiviral activity of the drug «Thymogen®», nasal dosed spray, against SARS-CoV-2 coronavirus <i>in vitro</i> by I. A. Leneva, V. S. Smirnov, T. A. Kudryavtseva, E. B. Fayzuloev, A. V. Gracheva, N. P. Kartashova, V. A. Zaplutanov, S. V. Petlenko

    Published 2021-08-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Pseudoneutralizing test for preclinical studies of vaccines against SARS-CoV-2

    Pseudoneutralizing test for preclinical studies of vaccines against SARS-CoV-2 by B. S. Cherepovich, A. M. Kudryashova, N. P. Kartashova, A. V. Gracheva, V. A. Manuilov, I. A. Leneva, O. V. Borisova, O. A. Svitich

    Published 2024-04-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Possibilities of suppressing the cytopathogenic effect of SARS-CoV-2 coronavirus according to the results of the antiviral activity of Cytovir®-3 <i>in vitro</i> study

    Possibilities of suppressing the cytopathogenic effect of SARS-CoV-2 coronavirus according to the results of the antiviral activity of Cytovir®-3 <i>in vitro</i> study by V. S. Smirnov, I. A. Leneva, T. A. Kudryavtseva, E. B. Fayzuloev, V. A. Zaplutanov, S. V. Petlenko, N. P. Kartashova, A. V. Gracheva, E. R. Korchevaya

    Published 2021-08-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Investigation of Susceptibility of Influenza Viruses A (H1N1), the Cause of Infection in Humans in April - May 2009, to Antivirals in MDCK Cell Culture

    Investigation of Susceptibility of Influenza Viruses A (H1N1), the Cause of Infection in Humans in April - May 2009, to Antivirals in MDCK Cell Culture by A. A. Romanovskaya, A. M. Durymanov, K. A. Sharsov, A. V. Zaikovskaya, I. M. Susloparov, A. M. Shestopalov, I. A. Leneva, I. G. Drozdov

    Published 2020-05-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Umifenovir (Arbidol) Efficacy in Experimental Mixed Viral and Bacterial Pneumonia of Mice

    Umifenovir (Arbidol) Efficacy in Experimental Mixed Viral and Bacterial Pneumonia of Mice by I. A. Leneva, I. N. Falynskova, E. I. Leonova, I. T. Fedyakina, N. R. Makhmudova, E. A. Osipova, L. N. Lepekha, N. A. Mikhailova, V. V. Zverev

    Published 2020-05-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Antiviral Activity of Cytovir<sup>®</sup>-3 Against Human Rotavirus Infection Agent <i>in vitro</i>

    Antiviral Activity of Cytovir<sup>®</sup>-3 Against Human Rotavirus Infection Agent <i>in vitro</i> by E. B. Faizuloev, I. A. Leneva, V. S. Smirnov, D. I. Smirnova, A. V. Gracheva, E. R. Korchevaya, D. M. Khokhlova, T. A. Kudryavtseva, S. V. Petlenko, V. A. Zaplutanov

    Published 2024-06-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: